You are here
- Home
Sitemap
-
-
Prostate cancer news
-
Prostate cancer
-
AstraZeneca products
-
Treatment Guidelines for prostate cancer
- NCCN – National Comprehensive Cancer Network – The NCCN – Prostate Cancer – Clinical Practice Guidelines in Oncology – V2.2009 – 46 pages
- NICE – National Institute for Health and Clinical Excellence – Prostate Cancer – Diagnosis and Treament – NICE Guideline 58 – February 2008 – 41 pages
- EAU – Guidelines on Prostate Cancer – 2007 – 114 pages
- AUA – Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update – 82 Pages
- ASCO - Initial hormonal management of androgen-sensitive metastatic, recurrent, or progressive prostate cancer: 2006 Update of an American Society of Clinical Oncology Practice Guideline – 9 Pages
- ESMO - Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer – 2005
- ACN – Clinical Practice Guidelines: Evidence based information and recommendations for the management of localised prostate cancer – 2002
- NCCC – Clinical Practice Guidelines – Prostate Cancer
- RCR COIN/BAUS – Guidelines on the management of prostate cancer – 1999
-
Not signed in
Information
This is an AstraZeneca International website for healthcare professionals and is not intended for the following audiences who should use the links below.
